Momenta Pharmaceuticals Inc (NASDAQ:MNTA)

14.67
Delayed Data
As of Mar 05
 +0.57 / +4.04%
Today’s Change
9.38
Today|||52-Week Range
16.25
+21.84%
Year-to-Date

Stock Price Forecast

The 9 analysts offering 12-month price forecasts for Momenta Pharmaceuticals Inc have a median target of 15.00, with a high estimate of 17.00 and a low estimate of 7.00. The median estimate represents a +2.25% increase from the last price of 14.67.

Analyst Recommendations

The current consensus among 9 polled investment analysts is to Buy stock in Momenta Pharmaceuticals Inc. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.45
Sales
$11.6M
Reporting Date
May 07

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -43.64%
 
 
 
 
 
 
Growthannually 79.02%
 
 
 
 
 
 

Sales

Growthquarterly -45.01%
 
 
 
 
 
 
Growthannually 170.54%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account